It protects dopaminergic neurons from oxidative stressed DNA damageand alleviate key pathological features of PD including oxidative stress, mitochondrial dysfunction and neurodegeneration, backing up its therapeutic potential for neurodegenerative diseases (Lin et al., 2021
In a recent observational study, individuals who discontinued semaglutide or tirzepatide within the first three months lost only 3.6% of their body weight, while those who quit between three and twelve months lost 6.8%
Retatrutide's profile will sharpen as the remaining seven TRIUMPH trials report over 2026
Anyway, uh, This family of peptides goes back 20 years and have been prescribed successfully with great safety and efficacy
Back Karamanou, M, Protogerous, A, Tsoucalas, G, et al (10 Jan 2016) 'Milestones in the history of diabetes mellitus: The main contributors', World Journal Diabetes , 7/1, 1-7
The best part